Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients.

ABSTRACT:

Background

Observational studies suggest an inequitable prescription of biologics in psoriasis care, which may be attributed to geographical differences in treatment access. Sweden regularly ranks high in international comparisons of equitable healthcare, and is, in connection with established national registries, an ideal country to investigate potential inequitable access.

Objective

The aim was to determine whether the opportunity for patients to receive biologics depends on where they receive care.

Methods

Biologic-naïve patients enrolled in the Swedish National Register for Systemic Treatment of Psoriasis (PsoReg) from 2008 to 2015 (n = 4168) were included. The association between the likelihood of initiating a biologic and the region where patients received care

SUBMITTER: Calara PS 

PROVIDER: S-EPMC5258782 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature